Immunity and immunopathology in dengue virus infections
- PMID: 1617166
Immunity and immunopathology in dengue virus infections
Abstract
Dengue virus infections are a serious public health problem in tropical and subtropical areas of the world. Based on epidemiological data, it has been postulated that immune responses to dengue virus contribute to the pathogenesis of severe dengue illness, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Host immune responses are also important for controlling dengue virus infection. Therefore, dengue virus infections are an interesting model to explore the interactions between viruses and the immune system which result in immunopathology or recovery from infection. In this paper, we review immune responses to dengue viruses with an emphasis on the human T cell responses, and discuss possible roles of these immune responses in the control of dengue virus infection and in the pathogenesis of DHF/DSS.
Similar articles
-
Human immune responses to dengue viruses.Southeast Asian J Trop Med Public Health. 1990 Dec;21(4):658-62. Southeast Asian J Trop Med Public Health. 1990. PMID: 1983049
-
Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.Exp Biol Med (Maywood). 2008 Apr;233(4):401-8. doi: 10.3181/0707-MR-198. Exp Biol Med (Maywood). 2008. PMID: 18367628 Review.
-
[Dengue. A review].Invest Clin. 1991;32(4):201-17. Invest Clin. 1991. PMID: 1822723 Review. Spanish.
-
[Dengue virus-specific antigen lymphoproliferation assay with human T cells].Rev Cubana Med Trop. 2000 Sep-Dec;52(3):197-202. Rev Cubana Med Trop. 2000. PMID: 11826523 Spanish.
-
Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.Vaccine. 2009 Oct 30;27(46):6444-53. doi: 10.1016/j.vaccine.2009.06.061. Epub 2009 Jul 4. Vaccine. 2009. PMID: 19580892
Cited by
-
Ophthalmic complications of dengue.Emerg Infect Dis. 2006 Feb;12(2):285-9. doi: 10.3201/eid1202.050274. Emerg Infect Dis. 2006. PMID: 16494756 Free PMC article.
-
Virus replication and cytokine production in dengue virus-infected human B lymphocytes.J Virol. 2002 Dec;76(23):12242-9. doi: 10.1128/jvi.76.23.12242-12249.2002. J Virol. 2002. PMID: 12414963 Free PMC article.
-
Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice.J Virol. 2003 Dec;77(24):12941-9. doi: 10.1128/jvi.77.24.12941-12949.2003. J Virol. 2003. PMID: 14645550 Free PMC article.
-
Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in Malaysia.PLoS One. 2014 Mar 19;9(3):e92021. doi: 10.1371/journal.pone.0092021. eCollection 2014. PLoS One. 2014. PMID: 24647042 Free PMC article.
-
Development of an antigen capture immunoassay based on monoclonal antibodies specific for dengue virus serotype 2 nonstructural protein 1 for early and rapid identification of dengue virus serotype 2 infections.Clin Vaccine Immunol. 2009 Jan;16(1):88-95. doi: 10.1128/CVI.00212-08. Epub 2008 Nov 19. Clin Vaccine Immunol. 2009. PMID: 19020106 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical